CAL20.C SARS-CoV-2 variant skyrocketing in California evades host

In a study published on the bioRxiv* preprint server, researchers report the effect of neutralizing antibodies from recovered patients or mRNA vaccinated individuals on neutralizing this variant.

Reconstruction of transmission chains of SARS-CoV-2 amidst

CDC Library: COVID-19 Science Update: 2/19/2021

Distribution of SARS-CoV-2 Variants in a Large Integrated Health

New California Variant More Contagious, Two Studies Confirm - The

Newly identified COVID-19 strain in Los Angeles could be driving

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID

Striking antibody evasion manifested by the Omicron variant of

EX-99.2

Genomic epidemiology of the Los Angeles COVID-19 outbreak and the

Ken Ng (@ken_ngk) / X

Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants

Neurological and Neuropsychological Changes Associated with SARS

SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic

EX-99.2

Overcoming Culture Restriction for SARS-CoV-2 in Human Cells